Target Professions: DO, MD, MBBS, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Neurology, Infusion Specialist, Electromyography Specialist
Credits Available: 3.75 AMA PRA Category 1 Credit

Often seen in Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN), arise as a consequence of immune system involvement and can have myriad health consequences. Both CIDP and MMN are characterized by complex presentations and frequent misdiagnoses. CIDP shows gradual peripheral nerve demyelination, leading to weakness and sensory loss, while MMN presents with asymmetric weakness devoid of sensory complications. With an array of treatment options, managing polyneuropathy in CIDP and MMN can be challenging. This collaborative platform serves as a unifying space for healthcare providers, facilitating the exchange of insights and elevating the standard of care for patients affected by CIDP and MMN. In this learning activity, you will learn how to enhance the lives of CIDP and MMN patients via a program promoting local and cross-community support, driving effective practice-sharing for better outcomes.


CME/CE Accreditation Information

Itinerary

Part One - Baseline Assessment, Self Study, Live Group Discussion 1, Final Assessment

Turning Complexity into Clarity in Chronic Immune-Mediated Neuropathies - Baseline Assessment

The following questions are designed to assess your knowledge and practice of patients with CIDP and MMN.

Module 1: Differential Diagnosis of Chronic Immune-Mediated Polyneuropathies

This module will discuss the presentation and differential diagnoses for CIDP and MMN.

Module 2: Diagnostic Workup of Chronic Immune-Mediated Polyneuropathies

This module will discuss the approach for diagnosing CIDP and MMN.

Module 3: Treatment of Chronic Immune-Mediated Polyneuropathies

This module will discuss the treatments of CIDP and MMN, and emerging new formulations.

Turning Complexity into Clarity in Chronic Immune-Mediated Neuropathies - Final Assessment

The following questions are designed to assess your gained knowledge and practice of patients with CIDP and MMN.

Self-study Review

During this session, we will review the self-study modules and discuss approaches to treatment that offer optimal care to patients with CIDP and MMN.

Part Two - Group Challenge, Action Plan, Live Group Discussion 2

CIDP and MMN Group Challenge - Richard's Case

Meet Richard, a 71-year-old man who was brought to the ER after falling during an appointment with his family doctor.

Your CIDP/MMN action plan

In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with CIDP and MMN.

Patient Case Review

During this session, we will review the patient case and discuss treatment plans. Additionally, we will share our action plans and how this CME activity will shape our practice regarding patient care.

Interested in becoming a Group Leader?

Requirements:
Experts in the management of patients with CIDP and MMN, including physicians and advanced practice providers. Apply Now

You cannot sign up as a Group Member because there are no groups available or because you are already signed up.

Completed Groups

AS
Amro Stino, MD
Associate Professor
Completed
Vinay Chaudhry, MD
James F. Howard Jr. Distinguished Professor of Neurology
Completed
JC
Jeffrey Cohen, MD
Professor Neurology
Completed